在精神分裂症中白的氨酸皮肤发反应:元分析
Jinfeng Wang1, Qian Wang1, Dandan Wang1
1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
精神分裂症患者表现出显著减弱的氨酸皮肤发红反应 (NSFR),表明改善诊断的潜力. 标准化NSFR评估对于个性化精神分裂症干预至关重要.
科学领域:
- 精神病学和神经科学 精神病学和神经科学
- 生物标志物和诊断工具
背景情况:
- 精神分裂症的发病因子是复杂的,使诊断和治疗复杂化.
- 氨酸皮肤发反应 (NSFR) 是精神分裂症的潜在内分类型,但其患病率各不相同.
- 削弱的NSFR (BNR) 需要在精神分裂症方面进行进一步的调查.
研究的目的:
- 通过全面的元分析,澄清NSFR和精神分裂症之间的关系.
- 调查NSFR的特征,包括反应程度,速度,灵敏度和精神分裂症中BNR的患病率.
- 确定影响精神分裂症NSFR和BNR的因素.
主要方法:
- 在PubMed,Embase,Web of Science,Cochrane和Scopus数据库中进行系统搜索,直到2024年5月.
- 将32项符合条件的研究纳入元分析,使用随机效应模型.
- 亚组和回归分析以探索NSFR的效果修饰剂.
主要成果:
- 与健康对照组 (HC) 相比,精神分裂症 (SZ) 中NSFR的反应程度,速度和敏感性显著降低.
- 化NSFR (BNR) 和SZ (OR = 8.50) 之间存在强烈的正相关性.
- 在SZ中,BNR的发病率较高 (58.5%),而不是HC (11.8%).
结论:
- 异常NSFR和SZ中BNR患病率增加证实了其作为诊断和治疗生物标志物的潜力.
- 研究结果支持在精神分裂症小组中使用NSFR进行个性化干预策略.
- 建议使用标准化的NSFR评估方法来提高临床效用.
更多相关视频
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
12:00Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
Published on: November 19, 2014
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
CNS Depressants: Alcohol and Nicotine
Psychosis: Goals of Pharmacotherapy
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
